These new breakthroughs lay an important foundation for future researches on the mechanism of METTL1–WDR4‐mediated m7G‐tRNA modification in cancer occurrence and provide new ideas to design and develop METTL1–WDR4 methyltransferase inhibitors as potential novel anticancer medications. This evidence concerns the gene WDR4 and cancer.